Dr. Edward Garon, David Geffen School of Medicine at UCLA, reviews the landmark Biomarkers France study that tested a wide range of molecular markers in NSCLC.
Dr. Edward Garon, David Geffen School of Medicine at UCLA, reviews the landmark Biomarkers France study that tested a wide range of molecular markers in NSCLC.
leggi di più
leggi meno
10 anni fa
#2013, #asco, #biomarkers, #cancergrace, #david, #dr, #edward, #france, #garon, #geffen, #grace, #gracecast, #medicine, #of, #school, #ucla
